Incremental Diagnostic Value and Impact on Patient Management of Somatostatin Receptor Scintigraphy with Indium-111-Pentetreotide in Gastroenteropancreatic Neuroendocrine Tumors

Publisher： Karger

E-ISSN： 1423-0151|20|4|356-361

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.20, Iss.4, 2011-05, pp. : 356-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors

By  

Digestion, Vol. 96, Iss. 1, 2017-06 ,pp. : 13-20

Karger

Access to resources Recommend Favorite

Influence of Somatostatin Receptor Scintigraphy and CT/MRI on the Clinical Management of Patients with Gastrointestinal Neuroendocrine Tumors: An Analysis in 188 Patients

By  

Digestion, Vol. 68, Iss. 2-3, 2004-01 ,pp. : 80-85

Karger

Access to resources Recommend Favorite

Somatostatin receptor imaging for neuroendocrine tumors

By de Herder Wouter   Kwekkeboom Dik   Feelders Richard   van Aken Maarten   Lamberts Steven   van der Lely Aart-Jan   Krenning Eric  

Pituitary, Vol. 9, Iss. 3, 2006-09 ,pp. : 243-248

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of neuroendocrine tumors with somatostatin analogs

By Janson Eva  

Pituitary, Vol. 9, Iss. 3, 2006-09 ,pp. : 249-256

Springer Publishing Company

Access to resources Recommend Favorite

Biological and Molecular Aspects of Gastroenteropancreatic Neuroendocrine Tumors

By  

Digestion, Vol. 62, Iss. 1, 2000-07 ,pp. : 19-26

Karger

Access to resources Recommend Favorite